Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregrel vs Plavix in Patients Undergoing PCI
NCT01349777Phase 4Completed
- Start
- Mar 2010
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Pregrel in coronary artery disease (CAD). Primary endpoint: Major Adverse Cardiovascular Events at 12 months. Started Mar 2010; status: completed.
02
Drugs
Pregrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01349777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01349777.